Briviact 10 MG/ML oral soln 300ML
Ended Awarded Last action
- Contract number
- SPE2DR26FDA7U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,223
Award facts
- Contract value 100% obligated
- $18,222.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,222.96 to AmerisourceBergen Drug Corp for Briviact 10 mg/mL oral solution (300 mL) on January 21, 2026, with an ultimate completion date of January 22, 2026. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies to federal government agencies, particularly the Department of Defense and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products and medical commodities across multiple therapeutic domains. The IDC with DLA Troop Support Medical enables the company to efficiently fulfill government procurement requirements for specialty medications, brand-name and generic drugs, vaccines, and other medical supplies needed by military treatment facilities and federal healthcare institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26FDA7U?
SPE2DR26FDA7U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FDA7U worth?
The government has obligated $18,223 on SPE2DR26FDA7U.
Is contract SPE2DR26FDA7U an order under another contract?
Yes. SPE2DR26FDA7U is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDA7U competed?
The extent of competition for SPE2DR26FDA7U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award